Glycoprotein G

Product Inquiry

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Technetium Tc 99m tilmanoceptNEO3-09ApprovedUniversity Of CaliforniaLymphoseek Kit, Lymphoseek, LymphoaimUnited StatesSolid tumours; Head and Neck Neoplasms; Melanoma; Carcinoma, Squamous Cell; Breast Neoplasms; Diagnostic agentsCardinal Health 414 Llc2013-03-13Arthritis, Rheumatoid; Uterine Cervical Neoplasms; Sarcoma, Kaposi; Melanoma; Endometrial Neoplasms; Diagnostic agents; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Liver Neoplasms; Colonic Neoplasms; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Metabolic Dysfunction-Associated Steatotic Liver Disease; Head and Neck Neoplasms; Solid tumours; HIV Infections
Details
  • Product Inquiry
  • Marketed Drug Information